Eloísa Bonfá

17.3k total citations
426 papers, 10.3k citations indexed

About

Eloísa Bonfá is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eloísa Bonfá has authored 426 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 269 papers in Rheumatology, 123 papers in Immunology and 71 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eloísa Bonfá's work include Systemic Lupus Erythematosus Research (227 papers), Monoclonal and Polyclonal Antibodies Research (66 papers) and Autoimmune and Inflammatory Disorders Research (52 papers). Eloísa Bonfá is often cited by papers focused on Systemic Lupus Erythematosus Research (227 papers), Monoclonal and Polyclonal Antibodies Research (66 papers) and Autoimmune and Inflammatory Disorders Research (52 papers). Eloísa Bonfá collaborates with scholars based in Brazil, United States and Argentina. Eloísa Bonfá's co-authors include Eduardo Ferreira Borba, Clóvis A. Silva, Rosa Maria Rodrigues Pereira, Jozélio Freire de Carvalho, Keith B. Elkon, Nádia Emi Aikawa, Sandra Gofinet Pasoto, Bruno Gualano, Ana Cristina de Medeiros Ribeiro and Nathan Brot and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Eloísa Bonfá

410 papers receiving 10.1k citations

Peers

Countries citing papers authored by Eloísa Bonfá

Since Specialization

Citations

This map shows the geographic impact of Eloísa Bonfá's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eloísa Bonfá with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eloísa Bonfá more than expected).

Fields of papers citing papers by Eloísa Bonfá

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eloísa Bonfá. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eloísa Bonfá. The network helps show where Eloísa Bonfá may publish in the future.

Co-authorship network of co-authors of Eloísa Bonfá

This figure shows the co-authorship network connecting the top 25 collaborators of Eloísa Bonfá. A scholar is included among the top collaborators of Eloísa Bonfá based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eloísa Bonfá. Eloísa Bonfá is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy of switching from originator adalimumab to biosimilar adalimumab-AACF in patients with axial spondyloarthritis: a 12-month observational study 2025 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Karina Rossi Bonfiglioli, Nádia Emi Aikawa, (unknown), Renata Miossi, Fernando Henrique Carlos de Souza, (unknown), (unknown), Emily Figueiredo Neves Yuki, Eloísa Bonfá, Carla Gonçalves Schahin Saad, Ana Cristina de Medeiros Ribeiro, Júlio César Bertacini de Moraes, (unknown)	1
2	Disease Safety, Immunogenicity, and Efficacy of Recombinant Herpes Zoster Vaccine (RZV or Shingrix) in Autoimmune Rheumatic Diseases 2025 ·JCR Journal of Clinical Rheumatology ·Léonard de Vinci Kanda Kupa, Ana Cristina de Medeiros Ribeiro, Nádia Emi Aikawa, Sandra Gofinet Pasoto, Eduardo Ferreira Borba, (unknown), Carla Gonçalves Schahin Saad, Emily Figueiredo Neves Yuki, Luciana Parente Costa Seguro, (unknown), Samuel Katsuyuki Shinjo, Percival D. Sampaio‐Barros, (unknown), Júlio César Bertacini de Moraes, Vanderson de Souza Sampaio, (unknown), Clóvis A. Silva, Eloísa Bonfá	1
3	Physical Activity: A Strategy to Improve Antibody Response to a SARS-CoV-2 Vaccine Booster Dose in Patients With Autoimmune Rheumatic Diseases 2023 ·Journal of Physical Activity and Health ·Bruno Gualano, Sofia Mendes Sieczkowska, Ítalo Ribeiro Lemes, Rafael Pires da Silva, Ana Jéssica Pinto, (unknown), Fabiana Infante Smaira, Nádia Emi Aikawa, Léonard de Vinci Kanda Kupa, Sandra Gofinet Pasoto, Ana Cristina de Medeiros Ribeiro, Carla Gonçalves Schahin Saad, (unknown), Clóvis A. Silva, Paul Swinton, Pedro Curi Hallal, Hamilton Roschel, Eloísa Bonfá	0
4	Custeio Baseado em Atividade e Tempo (TDABC) do modelo CEDMAC de terapia assistida para dispensação de medicamentos imunobiológicos para doenças reumatológicas no SUS 2022 ·Michelle Lopes, (unknown), Eloísa Bonfá, (unknown)	1
5	Inactivated SARS-CoV-2 vaccine in primary Sjögren’s syndrome: humoral response, safety, and effects on disease activity 2022 ·Clinical Rheumatology ·Sandra Gofinet Pasoto, (unknown), Lissiane Karine Noronha Guedes, Ana Cristina de Medeiros Ribeiro, Emily Figueiredo Neves Yuki, Carla Gonçalves Schahin Saad, Clóvis A. Silva, Léonard de Vinci Kanda Kupa, (unknown), (unknown), (unknown), (unknown), Elaine Pires Leon, Cleonice Bueno, Tatiana do Nascimento Pedrosa, (unknown), (unknown), Nádia Emi Aikawa, Eloísa Bonfá	7
6	Physical activity and antibody persistence 6 months after the second dose of CoronaVac in immunocompromised patients 2022 ·Scandinavian Journal of Medicine and Science in Sports ·Bruno Gualano, Ítalo Ribeiro Lemes, Rafael Pires da Silva, Ana Jéssica Pinto, (unknown), Fabiana Infante Smaira, Sofia Mendes Sieczkowska, Nádia Emi Aikawa, Sandra Gofinet Pasoto, Ana Cristina de Medeiros Ribeiro, Carla Gonçalves Schahin Saad, (unknown), Clóvis A. Silva, Paul Swinton, Pedro Curi Hallal, Hamilton Roschel, Eloísa Bonfá	4
7	Gathering patients and rheumatologists' perceptions to improve outcomes in idiopathic inflammatory myopathies 2022 ·Clinics ·(unknown), (unknown), Fernando Henrique Carlos de Souza, Renata Miossi, (unknown), Samuel Katsuyuki Shinjo, Eloísa Bonfá, Michelle Lopes	2
8	Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis 2022 ·Joint Bone Spine ·Carla Gonçalves Schahin Saad, (unknown), (unknown), Júlio César Bertacini de Moraes, Cláudia Goldenstein‐Schainberg, Célio Roberto Gonçalves, (unknown), Nádia Emi Aikawa, Emily Figueiredo Neves Yuki, Sandra Gofinet Pasoto, Léonard de Vinci Kanda Kupa, (unknown), (unknown), Clóvis A. Silva, Ana Cristina de Medeiros Ribeiro, Eloísa Bonfá	8
9	Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose 2022 ·Clinics ·Rosa Maria Rodrigues Pereira, (unknown), Valéria F. Caparbo, Lucas Peixoto Sales, Sandra Gofinet Pasoto, Clóvis A. Silva, Emily Figueiredo Neves Yuki, Carla Gonçalves Schahin Saad, Ana Cristina de Medeiros Ribeiro, Léonard de Vinci Kanda Kupa, Solange Fusco, (unknown), (unknown), Carmen Sílvia Valente Barbas, Samuel Katsuyuki Shinjo, Nádia Emi Aikawa, Eloísa Bonfá	1
10	Adherence to non-pharmacological preventive measures among healthcare workers in a middle-income country during the first year of the COVID-19 pandemic: Hospital and community setting 2021 ·American Journal of Infection Control ·Sílvia Figueiredo Costa, Sebastián Vernal, Pedro Giavina‐Bianchi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Alberto José da Silva Duarte, Eloísa Bonfá, (unknown), (unknown), Aluísio Augusto Cotrim Segurado, Anna S. Levin	4
11	2019-EULAR/ACR classification criteria domains at diagnosis: predictive factors of long-term damage in systemic lupus erythematosus 2021 ·Clinical Rheumatology ·(unknown), Nádia Emi Aikawa, Sandra Gofinet Pasoto, (unknown), (unknown), (unknown), Eduardo Ferreira Borba, (unknown), Clóvis A. Silva, Eloísa Bonfá	7
12	Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints 2020 ·Kidney International Reports ·Salem Almaani, Udayan Bhatt, Cristina Arriens, Eloísa Bonfá, Maria Dall’Era, Frédéric Houssiau, Kenneth Kalunian, (unknown), Jorge Sánchez‐Guerrero, Neil Solomons, Brad H. Rovin	0
13	How COVID-19 is changing rheumatology clinical practice 2020 ·Nature Reviews Rheumatology ·Eloísa Bonfá, Laure Gossec, David Isenberg, Zhanguo Li, Soumya Raychaudhuri	25
14	Ankylosing spondylitis and psoriatic arthritis: revisiting screening of latent tuberculosis infection and its follow-up during anti-tumor necrosis factor therapy in an endemic area 2020 ·Clinics ·(unknown), Ana Cristina de Medeiros Ribeiro, Renata Miossi, Karina Rossi Bonfiglioli, Júlio César Bertacini de Moraes, Célio Roberto Gonçalves, Percival D. Sampaio‐Barros, Cláudia Goldenstein‐Schainberg, Fernando Henrique Carlos de Souza, (unknown), (unknown), Emily Figueiredo Neves Yuki, Eloísa Bonfá, Carla Gonçalves Schahin Saad	5
15	Applying the 2019 EULAR/ACR lupus criteria to patients from an established cohort: a Latin American perspective 2020 ·RMD Open ·Guillermo Pons‐Estel, Manuel F. Ugarte‐Gil, (unknown), Daniel Wojdyla, Rosana Quintana, Verónica Saurit, Enrique R. Soriano, Eloísa Bonfá, Loreto Massardo, Mario H. Cardiel, Luis M. Vilá, Russell Griffin, Bernardo A. Pons‐Estel, Graciela S. Alarcón	21
16	Anti-collagen type v: a marker of early systemic sclerosis? 2019 ·Advances in Rheumatology ·Michelle Lopes, Elenice Mantovani, Virgínia Lúcia Nazário Bonoldi, Ana Cristina de Medeiros Ribeiro, Eloísa Bonfá, Natalino H. Yoshinari, Danieli Andrade	6
17	Is serum uric acid a predictor of long-term renal outcome in lupus nephritis? 2019 ·Clinical Rheumatology ·Michelle Lopes, (unknown), Elaine Pires Leon, (unknown), Eduardo Ferreira Borba, Eloísa Bonfá	15
18	CE-45 Baseline factors predictive of the occurrence of neuropsychiatric damage accrual in latin american patients with systemic lupus erythematosus 2016 ·Bernardo A. Pons‐Estel, Daniel Wojdyla, Graciela S. Alarcón, Guillermo Pons‐Estel, Manuel F. Ugarte‐Gil, Francisco Caeiro, Enrique R. Soriano, Mercedes García, João Carlos Tavares Brenol, Eloísa Bonfá, Fernando Cavalcanti, Gloria Vásquez, Marlene Guibert-Toledano, Óscar Neira, Mario H. Cardiel, Virginia Pascual‐Ramos, (unknown), María H Esteva-Spinetti, Leonor Barile-Fabris	1
19	High Rate of Serious Infection in Juvenile Idiopathic Arthritis Under Biologic Therapy in a Real Life Setting 2016 ·Arthritis & Rheumatism ·(unknown), (unknown), Adriana Maluf Elias Sallum, Cláudia Goldenstein‐Schainberg, Eloísa Bonfá, Clóvis A. Silva, Nádia Emi Aikawa	0
20	Outcome of 847 Childhood-Onset Systemic LUPUS Erythematousus Patients in Three Age Groups 2016 ·UNESP Institutional Repository (São Paulo State University) ·(unknown), Natali W.S. Gormezano, (unknown), Nádia Emi Aikawa, Rosa Maria Rodrigues Pereira, Maria Teresa R. A. Terreri, Cláudia Saad Magalhães, (unknown), Ana Paula Sakamoto, Adriana Maluf Elias Sallum, Simone Appenzeller, Virgínia Paes Leme Ferriani, Cássia Maria Passarelli Lupoli Barbosa, (unknown), Adriana A. de Jesus, Luís Eduardo Coelho Andrade, Lúcia Maria Arruda Campos, Eloísa Bonfá, Clóvis A. Silva	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact